119 related articles for article (PubMed ID: 8102426)
1. Tamoxifen and endometrial lesions.
Neven P
Lancet; 1993 Aug; 342(8869):452. PubMed ID: 8102426
[No Abstract] [Full Text] [Related]
2. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
3. ACOG committee opinion. No. 336: Tamoxifen and uterine cancer.
American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
Obstet Gynecol; 2006 Jun; 107(6):1475-8. PubMed ID: 16738185
[TBL] [Abstract][Full Text] [Related]
4. One step forward or one step back with tamoxifen?
Gelmon K
Lancet; 2000 Sep; 356(9233):868-9. PubMed ID: 11036885
[No Abstract] [Full Text] [Related]
5. Tamoxifen and the uterus and endometrium.
Stewart HJ; Knight GM
Lancet; 1989 Feb; 1(8634):375-6. PubMed ID: 18446929
[No Abstract] [Full Text] [Related]
6. [Breast cancer, tamoxifen, and uterus].
Palacios A; Pertusa S; Montoya A; Martínez San Pedro R
Med Clin (Barc); 1993 Mar; 100(12):479. PubMed ID: 8479228
[No Abstract] [Full Text] [Related]
7. Tamoxifen and endometrial neoplasia.
Barakat RR
Clin Obstet Gynecol; 1996 Sep; 39(3):629-40. PubMed ID: 8862888
[No Abstract] [Full Text] [Related]
8. Endometrial cancer and tamoxifen.
Burke C
Clin J Oncol Nurs; 2005 Apr; 9(2):247-9. PubMed ID: 15853168
[No Abstract] [Full Text] [Related]
9. Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
Love RR
J Natl Cancer Inst; 1994 Jul; 86(13):1025-6. PubMed ID: 8007012
[No Abstract] [Full Text] [Related]
10. [Uterine pathology in women with breast cancer treated with tamoxifen].
Carcangiu ML
Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
[No Abstract] [Full Text] [Related]
11. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
Cuzick J; Forbes JF; Sestak I; Cawthorn S; Hamed H; Holli K; Howell A;
J Natl Cancer Inst; 2007 Feb; 99(4):272-82. PubMed ID: 17312304
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
Kuwashima Y; Kurosumi M; Kobayashi Y; Tanuma J; Suemasu K; Higashi Y; Kasamatsu T; Shiromizu K; Matsuzawa M; Kishi K
Anticancer Res; 1996; 16(5A):2993-6. PubMed ID: 8917418
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen and progesterone receptor status in breast cancer and development of endometrial abnormalities.
Cohen I; Altaras M; Rosen DJ; Shapira Y; Cordoba M; Yigael D; Beyth Y
Lancet; 1992 Aug; 340(8814):312. PubMed ID: 1353229
[No Abstract] [Full Text] [Related]
15. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.
Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE
Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892
[TBL] [Abstract][Full Text] [Related]
16. Endometrial cancer during tamoxifen treatment.
Powles TJ; Ashley S
Lancet; 1994 Apr; 343(8903):978. PubMed ID: 7909032
[No Abstract] [Full Text] [Related]
17. The risk of developing uterine sarcoma after tamoxifen use.
Lavie O; Barnett-Griness O; Narod SA; Rennert G
Int J Gynecol Cancer; 2008; 18(2):352-6. PubMed ID: 18334013
[TBL] [Abstract][Full Text] [Related]
18. Should tamoxifen users be screened for endometrial lesions?
Neven P; Vergote I
Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866
[No Abstract] [Full Text] [Related]
19. Re: Gynaecological effects of tamoxifen.
Lewis JP
J Clin Pathol; 2000 Jun; 53(6):484. PubMed ID: 10911811
[No Abstract] [Full Text] [Related]
20. [Use of liquid-based endometrial cytology in breast cancer patients receiving tamoxifen].
Protasova AÉ; Raskin GA; Orlova RV; Protasov DA; Tiukavina NV
Vopr Onkol; 2011; 57(5):675-9. PubMed ID: 22238943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
